- NEWS
China’s first mRNA vaccine is close — will that solve its COVID woes?
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
doi: https://doi.org/10.1038/d41586-022-01690-3
References
McMenamin, M. E. et al. Preprint at medRxiv https://doi.org/10.1101/2022.03.22.22272769 (2022).
Hui, A.-M. et al. Preprint at SSRN https://doi.org/10.2139/ssrn.4114061 (2022).
Liu, X. et al. Preprint at medRxiv https://doi.org/10.1101/2022.05.30.22275753 (2022).
Li, J.-X. et al. Lancet Respir. Med. https://doi.org/10.1016/S2213-2600(22)00087-X (2022).
Lauring, A. S. et al. BMJ 376, e069761 (2022).